ACT is a global community of professional scientists representing the pharmaceutical and biotech industries, regulatory agencies, contract research organizations, academia, and consulting firms. The mission of the College is to educate, lead, and serve scientists by promoting an exchange of information and perspectives on safety assessment and new developments related to applied toxicology.
BioCelerate, the preclinical subsidiary of TransCelerate, is hosting a preclinical symposium at this year’s event.